Delivery Order SPE2DB24D9113-SPE2DB25FEPUG

Award Date 12/4/24
Potential Completion Date 12/26/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D9113
    Indefinite Delivery Contract
  • SPE2DB24D9113-SPE2DB25FEPUG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,848.92, is for the supply of Xolair 300 mg/2 ml autoinjector syringes.

The contract is a firm fixed-price delivery order issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA. This IDC allows the DLA to place orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA through its previous contract awards.

Generated 3/5/25, 9:56 AM